Women Less Likely to Receive Screening or Counseling For HIV at STI Diagnosis
Women are less likely to be tested for HIV or offered prep at time of sexually transmitted infection diagnosis.
Women are less likely to be tested for HIV or offered prep at time of sexually transmitted infection diagnosis.
In adults with HIV aged >50 years, women have worse physical function and lower quality of life.
Prescribing macrolide antibiotics during the first trimester of pregnancy is associated with an increased risk for major fetal malformation.
Researchers sought to evaluate the clinical characteristics of the 2019 novel coronavirus disease in pregnancy and assess transmission potential of the infection to newborns.
A double-dose of inactivated influenza vaccine may not increase the immunogenicity of the vaccine among pregnant women with HIV.
Data from a large sample of Ebola survivors confirmed the persistence of Ebola viral RNA in semen for up to 6 months.
There are no major differences in pregnancy outcomes for women with HIV related to receipt of protease inhibitors, non-nucleoside reverse transcriptase inhibitors, or integrase strand transfer inhibitors.
The prevalence of neural tube defects (NTDs) in births to mothers with HIV from 2013 to 2017 was estimated to be 7.0 per 10,000 live births.
In addition to high antibody levels, factors including exposure to the human papillomavirus (HPV) and antibody avidity may be important and necessary to protect against infection.
Both the Revogene GBS LB and GeneXpert GBS LB assays perform well for the detection of Group B Streptococcal (GBS) infections in pregnant women.